INNOVATION AS THE KEY OF THE PHARMACEUTICAL COMPANIES’ COMPETITIVE ADVANTAGE

Beatrix Lanyi

GAZDÁLKODÁS: Scientific Journal on Agricultural Economics, 2007, vol. 51, issue Special Edition 19, 6

Abstract: Pharmaceutical industry belongs to the most innovative branches in Hungary. However as a consequence of increasing development costs and the strong competition on the market the means of gaining competitive advantage has become a focal point of the pharmaceutical companies’ strategy. Economic performance is highly dependent on research and knowledge and economic success is determined how companies are able to apply this knowledge and skills so how flourishing the product or technological development becomes. Only those branches and companies will gain competitive advantage that are able to compete on knowledge and technology. Since science and technology are considered to be the most important source of economic development, it contributes to the more effective restructuring and increased productivity.

Keywords: International; Development (search for similar items in EconPapers)
Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ageconsearch.umn.edu/record/58930/files/Lanyi_2007_19ksz_240_245.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ags:gazdal:58930

DOI: 10.22004/ag.econ.58930

Access Statistics for this article

More articles in GAZDÁLKODÁS: Scientific Journal on Agricultural Economics from Karoly Robert University College Contact information at EDIRC.
Bibliographic data for series maintained by AgEcon Search ().